GE HEALTHCARE A/S - CVR: 70979217

2023, DKK

06.05.2024

Bruttoresultat

9.360'

Primær drift

1.468'

Årets resultat

1.390'

Aktiver

30.791'

Kortfristede aktiver

30.791'

Egenkapital

14.354'

Afkastningsgrad

5 %

Soliditetsgrad

47 %

Likviditetsgrad

187 %

Resultat

06.05.2024

Årsrapport	2023 06.05.2024	2022 16.05.2023	2021 31.05.2022	2020 02.06.2021	2019 30.06.2020	2018 07.06.2019	2017 01.06.2018	2016 29.05.2017	2015 26.05.2016
Nettoomsætning
Bruttoresultat	9.360.438	9.032.842	9.427.429	10.646.450	12.342.330	12.122.109	13.699.078	12.500.182	0
Resultat af primær drift	1.468.231	1.651.469	1.663.031	2.103.386	1.671.419	1.863.993	2.170.682	1.536.487	0
Indtægter af kapitalandele (tilknyttede og associerede)	0	0	0	0	0	0	0	0	0
Finansielle indtægter	433.976	79.197	0	0	0	0	20.956	5.632	0
Finansieringsomkostninger	-102.183	0	-41.295	-132.881	-165.254	-274.621	-731.859	-698.825	0
Andre finansielle omkostninger	0	0	0	0	0	0	0	0	0
Resultat før skat	1.800.024	1.730.666	1.621.736	1.970.505	1.506.166	1.589.372	1.459.778	843.294	0
Resultat	1.389.896	1.342.346	1.257.494	1.531.882	1.094.907	1.294.900	1.133.507	657.769	0
Forslag til udbytte	0	0	-35.000.000	0	0	0	0	0	0

Aktiver

06.05.2024

Årsrapport	2023 06.05.2024	2022 16.05.2023	2021 31.05.2022	2020 02.06.2021	2019 30.06.2020	2018 07.06.2019	2017 01.06.2018	2016 29.05.2017
Kortfristede varebeholdninger	4.532.206	1.066.538	3.398.991	3.186.148	4.971.995	4.171.182	2.889.938	2.165.616
Kortfristede tilgodehavender fra salg og tjenesteydelser	26.258.367	20.990.436	51.070.844	49.174.577	51.901.133	54.445.282	52.379.958	49.055.387
Likvider	0	0	0	0	0	0	0	0
Kortfristede aktiver	30.790.573	22.056.974	54.469.835	52.360.725	56.873.128	58.616.464	55.269.896	51.221.002
Immaterielle aktiver og goodwill	0	0	0	0	0	0	0	0
Finansielle anlægsaktiver	0	0	0	0	0	0	0	0
Materielle aktiver	0	0	0	0	0	0	0	0
Langfristede aktiver	0	0	0	0	0	0	0	0
Aktiver	30.790.573	22.056.974	54.469.835	52.360.725	56.873.128	58.616.464	55.269.896	51.221.002

Aktiver

06.05.2024

Passiver

06.05.2024

Årsrapport	2023 06.05.2024	2022 16.05.2023	2021 31.05.2022	2020 02.06.2021	2019 30.06.2020	2018 07.06.2019	2017 01.06.2018	2016 29.05.2017
Forslag til udbytte	0	0	35.000.000	0	0	0	0	0
Egenkapital	14.354.281	12.964.385	46.622.039	42.101.512	40.569.630	39.474.724	38.179.824	37.046.317
Hensatte forpligtelser	0	0	0	0	0	0	0	0
Langfristet gæld til banker	0	0	0	0	0	0	0	0
Anden langfristet gæld			0	0	0	0	0	0
Leverandører af varer og tjenesteydelser	23.976	723.899	129.500	525.167	268.809	828.317	288.068	2.805.290
Kortfristede forpligtelser	16.436.292	9.092.589	7.847.796	10.259.213	16.303.498	19.141.740	17.090.072	14.174.686
Gældsforpligtelser	16.436.292	9.092.589	7.847.796	10.259.213	16.303.498	19.141.740	17.090.072	14.174.686
Forpligtelser	16.436.292	9.092.589	7.847.796	10.259.213	16.303.498	19.141.740	17.090.072	14.174.686
Passiver	30.790.573	22.056.974	54.469.835	52.360.725	56.873.128	58.616.464	55.269.896	51.221.002

Passiver

06.05.2024

Nøgletal

06.05.2024

Årsrapport	2023 06.05.2024	2022 16.05.2023	2021 31.05.2022	2020 02.06.2021	2019 30.06.2020	2018 07.06.2019	2017 01.06.2018	2016 29.05.2017	2015 26.05.2016
Afkastningsgrad	4,8 %	7,5 %	3,1 %	4,0 %	2,9 %	3,2 %	3,9 %	3,0 %	Na.
Dækningsgrad	Na.	Na.	Na.	Na.	Na.	Na.	Na.	Na.	Na.
Resultatgrad	Na.	Na.	Na.	Na.	Na.	Na.	Na.	Na.	Na.
Varelagerets omsætningshastighed	Na.	Na.	Na.	Na.	Na.	Na.	Na.	Na.	Na.
Egenkapitals-forretning	9,7 %	10,4 %	2,7 %	3,6 %	2,7 %	3,3 %	3,0 %	1,8 %	Na.
Payout-ratio	Na.	Na.	2.783,3 %	Na.	Na.	Na.	Na.	Na.	Na.
Gældsdæknings-nøgletal	1.436,9 %	Na.	4.027,2 %	1.582,9 %	1.011,4 %	678,8 %	296,6 %	219,9 %	Na.
Soliditestgrad	46,6 %	58,8 %	85,6 %	80,4 %	71,3 %	67,3 %	69,1 %	72,3 %	Na.
Likviditetsgrad	187,3 %	242,6 %	694,1 %	510,4 %	348,8 %	306,2 %	323,4 %	361,4 %	Na.

Resultat

06.05.2024

Gæld

06.05.2024

Årsrapport

06.05.2024

Nyeste:01.01.2023- 31.12.2023(offentliggjort: 06.05.2024)

Information om virksomhedens regnskabsklasse:The annual report of GE Healthcare A/S for 2023 has been presented in accordance with the provisions of the Danish Financial Statements Act applying to enterprises of reporting class B.

Beretning

06.05.2024

Dato for ledelsens godkendelse af årsrapporten:2024-04-30

Ledelsespåtegning: Today, Management has considered and adopted the Annual Report of GE Healthcare A/S for the financial year 1 January 2023 - 31 December 2023. The Annual Report is presented in accordance with the Danish Financial Statements Act. In our opinion, the Financial Statements give a true and fair view of the assets, liabilities and financial position of the Company at 31 December 2023 and of the results of the Company's operations for the financial year 1 January 2023 - 31 December 2023. In our opinion, the Management's Review includes a true and fair account of the matters addressed in the review. We recommend that the Annual Report be adopted at the Annual General Meeting. Brøndby, 30 April 2024 Executive Board Vibeke Gilving Man. Director Supervisory Board Arild Forland Vibeke Gilving Mark Frænkel Chairman Member Member Liselotte Cordua Member

Statement by Management on the annual report

Identifikation af den godkendte årsrapport:Today, Management has considered and adopted the Annual Report of GE Healthcare A/S for the financial year 1 January 2023 - 31 December 2023.

Management's review

Beskrivelse af virksomhedens væsentligste aktiviteter:The Company's principal activities The main activity of the Company is to trade in research- and pharmaceutical products, mainly sales of specialized products for the diagnosis of diseases. These include radiological contrast agents (X-ray / computed tomography or magnetic camera examination), ultrasound contrast agent for cardiology, and radiopharmaceuticals for diagnosis (SPECT, PET) and treatment. The Company is a distributor and part of the Pharmaceutical Diagnostics (PDx) business unit of GE HealthCare Technologies Inc.